Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Identification of epigenomic reprogramming in cancer and uses thereof

US Patent 11795510 · Granted Oct 24, 2023

Estimated economic value: $52,934,000

Assignee

Inventors

View full patent text on Google Patents →